HEALTH CARE:
BIOTECHNOLOGY & LIFE SCIENCES
SIC: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company is focused on the canine and feline companion animal health markets. It operates in two segments: Core Companion Animal Health and Other Vaccines, Pharmaceuticals and Products. The Core Companion Animal Health segment (CCA) includes diagnostic instruments and supplies, as well as single use diagnostic and other tests, vaccines and pharmaceuticals, primarily for canine and feline use. These products are sold directly by the Company as well as through independent third-party distributors and through other distribution relationships. The Other Vaccines, Pharmaceuticals and Products segment (OVP) includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals and fish. In February 2013, it announced the acquisition of 54.6% interest of Cuattro Veterinary USA, LLC.
Market Cap | 1.516 Billion | Shares Outstanding | 9.455 Million | Avg 30-day Volume | 76.461 Thousand |
P/E Ratio | -72.8 | Dividend Yield | EPS | -2.22 | |
Price/Sales | 11.398 | Price cash flow ratio | 159.9 | Price free cash flow ratio | -11.9 |
Book Value | 29.07 | Price to Tangible Book | 11.38 | Alpha | 0.01 |
Short Interest Ratio | % Short Interest to Float | R-squared | 0.269276 | ||
BETA | 1.64483 | 52-week High/Low | 163.63 / 50.0 | Stddev | 0.139478 |
Q3 2020 | All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|---|---|---|---|---|---|
In top 10: | 1 | 2 | -50.0% | 1 (0.07%) | 2 (0.13%) | -50.0% |
Funds Holding: | 125 | 127 | -1.57% | 28 (1.84%) | 27 (1.75%) | 3.7% |
13F shares: | 9.081 Million | 9.08 Million | 0.01% | 3.674 Million | 3.943 Million | -6.82% |
% Ownership | 96.1569 | 96.6793 | -0.54% | 38.9084 | 41.988 | -7.33% |
New Positions: | 10 | 20 | -50.0% | 4 | 7 | -42.86% |
Increased Positions | 54 | 58 | -6.9% | 11 | 11 | 0.0% |
Closed Positions | 10 | 13 | -23.08% | 2 | 6 | -66.67% |
Reduced Positions | 40 | 28 | 42.86% | 10 | 6 | 66.67% |
Total Calls | 0 | |||||
Total Puts | 2.88 Thousand | 0 | ||||
PUT/CALL Ratio | ||||||
1 hedge funds and active managers as identified by whalewisdom.com through public filings. |
Please sign in first
none
14.3 Thousand total shares from 7 transactions
30.6 Thousand total shares from 5 transactions
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
WILSON KEVIN S. CEO AND PRESIDENT |
|
396,333 | 2021-01-14 | 12 |
|
0 | 2021-01-11 | 2 | |
WISNEWSKI NANCY CHIEF OPERATING OFFICER |
|
51,874 | 2020-12-28 | 7 |
AROESTY JASON D EVP, INTERNATIONAL DIAGNOSTICS |
|
0 | 2020-11-27 | 1 |
|
420 | 2020-11-17 | 2 | |
|
4,089 | 2020-11-09 | 2 | |
SVEEN CHRISTOPHER D. CAO & GENERAL COUNSEL |
|
948 | 2020-09-24 | 3 |
BAKER ELEANOR F. EVP, MANAGING DIR. & COO, SCIL |
|
883 | 2020-09-24 | 3 |
|
1,284 | 2020-08-20 | 2 | |
GRASSMAN CATHERINE EVP, CFO |
|
3,723 | 2020-06-01 | 3 |
EYL STEVEN M. EVP, CCO & PRES.SCIL |
|
0 | 2020-04-16 | 2 |
|
6,839 | 2020-04-08 | 1 | |
|
32,741 | 2020-04-08 | 1 | |
|
5,112 | 2020-04-08 | 1 | |
|
2,957 | 2020-04-08 | 1 | |
NAPOLITANO JASON A CHIEF STRATEGY OFFICER |
|
62,799 | 2019-12-30 | 0 |
|
25,074 | 2018-11-29 | 0 | |
LIPPINCOTT ROD EVP, COMP. ANIMAL HEALTH SALES |
|
8,573 | 2018-08-31 | 0 |
ASAKOWICZ STEVE EVP, COMP. ANIMAL HEALTH SALES |
|
8,400 | 2018-08-27 | 0 |
|
5,249 | 2018-05-03 | 0 | |
MCGINLEY MICHAEL J PRESI, BIOLOGIC. & PHARM. |
|
86,776 | 2018-03-17 | 0 |
MCMAHON JOHN VP, CHIEF FINANCIAL OFFICER |
|
68 | 2017-08-30 | 0 |
GRIEVE ROBERT B EXECUTIVE CHAIR |
|
106,331 | 2015-08-28 | 0 |
|
37,397 | 2015-03-09 | 0 | |
BENT MICHAEL A V.P.ACTG. OFFICER & CONTROLLER |
|
9,773 | 2012-12-28 | 0 |
|
0 | 2012-12-19 | 0 | |
APERFINE JOSEPH EVP, SALES AND MARKETING |
|
0 | 2012-12-19 | 0 |
|
No longer subject to file | 2012-10-09 | 0 | |
|
0 | 2012-05-08 | 0 | |
|
0 | 2012-05-08 | 0 | |
|
0 | 2012-05-08 | 0 | |
|
579,045 | 2012-02-15 | 0 | |
SNODGRASS GERALD L VP, SALES |
|
0 | 2009-11-10 | 0 |
|
No longer subject to file | 2009-08-25 | 0 | |
FLANDERS JOHN R V.P., GENERAL COUNSEL |
|
32,500 | 2008-11-25 | 0 |
CHARTER VENTURES |
|
No longer subject to file | 2008-06-20 | 0 |
RITTER JOSEPH H EVP, GLOBAL BUS. OPERATIONS |
|
0 | 2007-12-31 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2021-01-15 16:02:54 -0500 | 2021-01-14 | F | 1,666 | $161.67 | d | 87,827 | direct | 1.3184 | 1.3184 | 2 | 0.0 | 1 | ||||
2021-01-15 16:02:54 -0500 | 2021-01-14 | M | 5,625 | a | 89,493 | direct | 1.3184 | 1.3184 | 2 | 0.0 | 1 | |||||
2021-01-15 16:02:54 -0500 | 2021-01-14 | M | 5,625 | d | 0 | direct | ||||||||||
2021-01-12 17:07:20 -0500 | 2021-01-11 | A | 235 | a | 235 | direct | 6.1036 | 7.4424 | 9.4441 | 5 | 0.0 | 1 | ||||
2021-01-05 14:28:44 -0500 | 2020-12-31 | F | 1,194 | $145.65 | d | 83,868 | direct | 5.133 | 2.3012 | 5.133 | 2 | 0.0 | 1 | |||
2021-01-05 14:28:44 -0500 | 2020-12-31 | A | 4,119 | a | 85,062 | direct | 5.133 | 2.3012 | 5.133 | 2 | 0.0 | 1 | ||||
2020-12-30 13:20:35 -0500 | 2020-12-28 | M | 6,000 | $4.96 | a | 51,874 | direct | -0.7631 | 5.696 | 8.0125 | 5 | -1.935 | 3 | |||
2020-12-30 13:20:35 -0500 | 2020-12-28 | M | 6,000 | d | 0 | direct | ||||||||||
2020-12-10 12:57:45 -0500 | 2020-12-09 | S | 200 | $140.61 | d | 45,874 | direct | 1.6129 | 7.5556 | 7.5556 | 6 | 0.0 | 1 | |||
2020-12-10 12:57:45 -0500 | 2020-12-09 | S | 300 | $140.23 | d | 46,074 | direct | 1.6129 | 7.5556 | 7.5556 | 6 | 0.0 | 1 | |||
2020-12-09 14:41:49 -0500 | 2020-12-08 | S | 150 | $133.28 | d | 46,374 | direct | -0.5135 | 4.8424 | 4.8424 | 6 | -0.5135 | 2 | |||
2020-12-09 14:41:49 -0500 | 2020-12-08 | S | 200 | $133.03 | d | 46,524 | direct | -0.5135 | 4.8424 | 4.8424 | 6 | -0.5135 | 2 | |||
2020-12-09 14:41:49 -0500 | 2020-12-07 | S | 150 | $131.00 | d | 46,724 | direct | -0.5135 | 4.8424 | 4.8424 | 6 | -0.5135 | 2 | |||
2020-12-03 15:55:57 -0500 | 2020-12-01 | M | 5,625 | d | 5,625 | direct | ||||||||||
2020-12-03 15:55:57 -0500 | 2020-12-01 | F | 1,631 | $123.96 | d | 80,943 | direct | 2.2487 | 11.0632 | 30.659 | 30.659 | 31 | 0.0 | 1 | ||
2020-12-03 15:55:57 -0500 | 2020-12-01 | M | 5,625 | a | 82,574 | direct | 2.2487 | 11.0632 | 30.659 | 30.659 | 31 | 0.0 | 1 | |||
2020-11-30 15:56:22 -0500 | 2020-11-27 | M | 11,460 | $106.67 | a | 11,460 | direct | -0.9842 | 12.3588 | 30.4211 | 30.4211 | 31 | -0.9842 | 2 | ||
2020-11-30 15:56:22 -0500 | 2020-11-27 | M | 11,460 | d | 5,729 | direct | ||||||||||
2020-11-30 15:56:22 -0500 | 2020-11-27 | S | 10,233 | $126.68 | d | 3,101 | direct | -0.9842 | 12.3588 | 30.4211 | 30.4211 | 31 | -0.9842 | 2 | ||
2020-11-30 15:56:22 -0500 | 2020-11-27 | M | 1,874 | d | 937 | direct | ||||||||||
2020-11-30 15:56:22 -0500 | 2020-11-27 | M | 1,874 | $106.67 | a | 13,334 | direct | -0.9842 | 12.3588 | 30.4211 | 30.4211 | 31 | -0.9842 | 2 | ||
2020-11-30 15:56:22 -0500 | 2020-11-27 | S | 3,101 | $127.44 | d | 0 | direct | -0.9842 | 12.3588 | 30.4211 | 30.4211 | 31 | -0.9842 | 2 |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |